NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,284 filers reported holding NOVARTIS A G in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,175,000 | +10.1% | 11,037 | +0.0% | 0.04% | +12.1% |
Q1 2024 | $1,067,416 | -8.6% | 11,035 | -4.6% | 0.03% | -17.5% |
Q4 2023 | $1,168,224 | -1.3% | 11,570 | -0.4% | 0.04% | -11.1% |
Q3 2023 | $1,183,818 | -1.8% | 11,622 | -2.7% | 0.04% | 0.0% |
Q2 2023 | $1,205,573 | +9.4% | 11,947 | -0.2% | 0.04% | +2.3% |
Q1 2023 | $1,101,701 | -2.7% | 11,975 | -4.0% | 0.04% | -10.2% |
Q4 2022 | $1,131,733 | +18.9% | 12,475 | -0.4% | 0.05% | +8.9% |
Q3 2022 | $952,000 | -7.1% | 12,521 | +3.2% | 0.04% | -2.2% |
Q2 2022 | $1,025,000 | -1.8% | 12,130 | +2.0% | 0.05% | +21.1% |
Q1 2022 | $1,044,000 | +0.2% | 11,895 | -0.2% | 0.04% | +11.8% |
Q4 2021 | $1,042,000 | +14.6% | 11,916 | +7.2% | 0.03% | 0.0% |
Q3 2021 | $909,000 | -10.4% | 11,116 | 0.0% | 0.03% | -10.5% |
Q2 2021 | $1,014,000 | +9.1% | 11,116 | +2.3% | 0.04% | -2.6% |
Q1 2021 | $929,000 | -11.9% | 10,864 | -2.7% | 0.04% | -17.0% |
Q4 2020 | $1,054,000 | +2.1% | 11,164 | -5.9% | 0.05% | -11.3% |
Q3 2020 | $1,032,000 | -0.6% | 11,869 | -0.2% | 0.05% | -11.7% |
Q2 2020 | $1,038,000 | +6.0% | 11,889 | 0.0% | 0.06% | -11.8% |
Q1 2020 | $979,000 | -13.3% | 11,889 | -0.3% | 0.07% | +4.6% |
Q4 2019 | $1,129,000 | +9.0% | 11,924 | 0.0% | 0.06% | -1.5% |
Q3 2019 | $1,036,000 | -8.2% | 11,924 | -3.4% | 0.07% | -9.6% |
Q2 2019 | $1,128,000 | -6.6% | 12,349 | -1.7% | 0.07% | -12.0% |
Q1 2019 | $1,208,000 | +6.9% | 12,566 | -4.6% | 0.08% | -21.0% |
Q4 2018 | $1,130,000 | -14.0% | 13,166 | -12.1% | 0.10% | -2.8% |
Q3 2018 | $1,314,000 | +23.5% | 14,972 | +15.6% | 0.11% | +33.3% |
Q2 2018 | $1,064,000 | +1.2% | 12,951 | -4.4% | 0.08% | -8.0% |
Q1 2018 | $1,051,000 | -9.5% | 13,549 | -0.9% | 0.09% | -14.6% |
Q4 2017 | $1,161,000 | +22.0% | 13,673 | +23.4% | 0.10% | -7.2% |
Q3 2017 | $952,000 | -0.4% | 11,083 | -1.2% | 0.11% | -4.3% |
Q2 2017 | $956,000 | +7.2% | 11,215 | -0.9% | 0.12% | +4.5% |
Q1 2017 | $892,000 | -2.4% | 11,315 | -8.8% | 0.11% | -9.0% |
Q4 2016 | $914,000 | -1.7% | 12,402 | +0.8% | 0.12% | -9.0% |
Q3 2016 | $930,000 | -40.1% | 12,302 | -34.3% | 0.13% | -38.8% |
Q2 2016 | $1,552,000 | +17.1% | 18,717 | +2.3% | 0.22% | +7.9% |
Q1 2016 | $1,325,000 | -4.0% | 18,292 | +3.1% | 0.20% | -15.1% |
Q4 2015 | $1,380,000 | -5.0% | 17,742 | +10.2% | 0.24% | -4.4% |
Q3 2015 | $1,453,000 | +2.1% | 16,103 | +11.3% | 0.25% | +0.4% |
Q2 2015 | $1,423,000 | +18.9% | 14,473 | +24.8% | 0.25% | +20.3% |
Q1 2015 | $1,197,000 | +22.9% | 11,597 | +13.4% | 0.21% | +13.1% |
Q4 2014 | $974,000 | +4.2% | 10,230 | +3.0% | 0.18% | -1.6% |
Q3 2014 | $935,000 | -1.7% | 9,930 | -5.5% | 0.19% | -13.9% |
Q2 2014 | $951,000 | +7.8% | 10,505 | +1.3% | 0.22% | -6.9% |
Q1 2014 | $882,000 | +5.8% | 10,370 | 0.0% | 0.23% | +3.6% |
Q4 2013 | $834,000 | +4.0% | 10,370 | -0.8% | 0.22% | -9.3% |
Q3 2013 | $802,000 | +13.8% | 10,450 | +4.8% | 0.25% | +6.5% |
Q2 2013 | $705,000 | – | 9,975 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |